These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. Park H; Huang X; Lu C; Cairo MS; Zhou X J Biol Chem; 2015 Jan; 290(5):2831-41. PubMed ID: 25505246 [TBL] [Abstract][Full Text] [Related]
24. MiR-146a Promotes Tolerogenic Properties of Dendritic Cells and through Targeting Notch1 Signaling. Tang H; Lai Y; Zheng J; Chen K; Jiang H; Xu G Immunol Invest; 2020 Jul; 49(5):555-570. PubMed ID: 31957545 [TBL] [Abstract][Full Text] [Related]
25. The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells. Doxsee CL; Riter TR; Reiter MJ; Gibson SJ; Vasilakos JP; Kedl RM J Immunol; 2003 Aug; 171(3):1156-63. PubMed ID: 12874201 [TBL] [Abstract][Full Text] [Related]
26. IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening ERK/NF-κB/S6K signalings. Wu W; Wang W; Wang Y; Li W; Yu G; Li Z; Fang C; Shen Y; Sun Z; Han L; Yu J; Fang L; Chen S; Dong K; Han Z; Liu H; Luo Y; Feng X Acta Biochim Biophys Sin (Shanghai); 2015 Aug; 47(8):597-603. PubMed ID: 26094142 [TBL] [Abstract][Full Text] [Related]
27. Tumor Dendritic Cells (DCs) Derived from Precursors of Conventional DCs Are Dispensable for Intratumor CTL Responses. Diao J; Gu H; Tang M; Zhao J; Cattral MS J Immunol; 2018 Aug; 201(4):1306-1314. PubMed ID: 29997124 [TBL] [Abstract][Full Text] [Related]
28. miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1. Lind EF; Millar DG; Dissanayake D; Savage JC; Grimshaw NK; Kerr WG; Ohashi PS J Immunol; 2015 Nov; 195(10):4632-40. PubMed ID: 26447227 [TBL] [Abstract][Full Text] [Related]
30. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Scott EA; Stano A; Gillard M; Maio-Liu AC; Swartz MA; Hubbell JA Biomaterials; 2012 Sep; 33(26):6211-9. PubMed ID: 22658634 [TBL] [Abstract][Full Text] [Related]
31. Shutdown of immunological priming and presentation after in vivo administration of adenovirus. Sutherland RM; Londrigan SL; Brady JL; Azher H; Carrington EM; Zhan Y; Vega-Ramos J; Villadangos JA; Lew AM Gene Ther; 2012 Nov; 19(11):1095-100. PubMed ID: 22089496 [TBL] [Abstract][Full Text] [Related]
32. Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Zhou M; Chen J; Zhou L; Chen W; Ding G; Cao L Cell Immunol; 2014; 292(1-2):65-9. PubMed ID: 25290620 [TBL] [Abstract][Full Text] [Related]
33. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. Nakamura K; Miyazato A; Xiao G; Hatta M; Inden K; Aoyagi T; Shiratori K; Takeda K; Akira S; Saijo S; Iwakura Y; Adachi Y; Ohno N; Suzuki K; Fujita J; Kaku M; Kawakami K J Immunol; 2008 Mar; 180(6):4067-74. PubMed ID: 18322216 [TBL] [Abstract][Full Text] [Related]
34. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Johnson S; Zhan Y; Sutherland RM; Mount AM; Bedoui S; Brady JL; Carrington EM; Brown LE; Belz GT; Heath WR; Lew AM Immunity; 2009 Feb; 30(2):218-27. PubMed ID: 19200758 [TBL] [Abstract][Full Text] [Related]
36. CD13 regulates dendritic cell cross-presentation and T cell responses by inhibiting receptor-mediated antigen uptake. Ghosh M; McAuliffe B; Subramani J; Basu S; Shapiro LH J Immunol; 2012 Jun; 188(11):5489-99. PubMed ID: 22544935 [TBL] [Abstract][Full Text] [Related]
37. TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells. Iyori M; Zhang T; Pantel H; Gagne BA; Sentman CL J Immunol; 2011 Sep; 187(6):3087-95. PubMed ID: 21832159 [TBL] [Abstract][Full Text] [Related]
38. Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA level. Pyfferoen L; Mestdagh P; Vergote K; De Cabooter N; Vandesompele J; Lambrecht BN; Vermaelen KY Int J Cancer; 2014 Dec; 135(12):2868-77. PubMed ID: 24789737 [TBL] [Abstract][Full Text] [Related]
39. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells. Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-146a protects against LPS-induced organ damage by inhibiting Notch1 in macrophage. Bai X; Zhang J; Cao M; Han S; Liu Y; Wang K; Han F; Li X; Jia Y; Wang X; Shi J; Hu D Int Immunopharmacol; 2018 Oct; 63():220-226. PubMed ID: 30103197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]